The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

The contrast between the FDA’s clinical lens and the raw realities in the Bonafide study highlights a critical disconnect ...

Experts on the panel shared many of the same views around SSRIs, arguing that the risks of the drugs during pregnancy are greater than currently accepted.

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...